Shenzhen Tianyuan Pharmaceutical Technology Co. Ltd.

Embarking on a mission to pioneer advancements in the health and medical industry, Shenzhen Tianyuan Pharmaceutical Technology Co., Ltd. stands as a distinguished manufacturer specializing in targeted anticancer drug research.

Nestled in the vibrant landscape of Guangdong, China, our company is committed to the relentless pursuit of excellence in the realms of researching, manufacturing, and marketing medical raw materials.

At the heart of our operations lie a diverse array of cutting-edge products. From crizotinib to afatinib, Capmatinib to Aloitinib, and an impressive portfolio featuring Sorafenib, Ibrutinib, Lenvatinib, and various TINI API and intermediates, we take pride in our role as innovators and contributors to the global pharmaceutical landscape.

Our commitment to precision, quality, and the pursuit of groundbreaking solutions is embedded in the fabric of Shenzhen Tianyuan Pharmaceutical Technology.

As we navigate the intricate world of targeted anticancer drug research, our vision extends beyond products; we envision a healthier, more resilient world through the impact of our pharmaceutical endeavors.

In Guangdong, China, we not only operate as a manufacturer but as pioneers shaping the future of medical raw materials, defining a legacy of innovation in the pharmaceutical sector.